Fineline Cube

Follow:
14778 Articles
Huahai Pharmaceutical to Transfer Rights to Innovative Antidepressant HHT001 via Public Listing
CompanyDeals

Huahai Pharmaceutical to Transfer Rights to Innovative Antidepressant HHT001 via Public Listing

Mabwell's 9MW2821 Granted Breakthrough Therapy Designation by CDE for Urothelial Carcinoma
CompanyDrug

Mabwell’s 9MW2821 Granted Breakthrough Therapy Designation by CDE for Urothelial Carcinoma

Kelun Pharmaceutical's Generic Mulpleta Gains NMPA Approval in China
CompanyDrug

Kelun Pharmaceutical’s Generic Mulpleta Gains NMPA Approval in China

Alloy Therapeutics and Sanofi Collaborate on CNS Drug Development with AntiClastic Antisense Platform
CompanyDeals

Alloy Therapeutics and Sanofi Collaborate on CNS Drug Development with AntiClastic Antisense Platform

Fujian Cosunter's COVID-19 Therapy GST-HG171/ritonavir Approved in Macau
CompanyDrug

Fujian Cosunter’s COVID-19 Therapy GST-HG171/ritonavir Approved in Macau

Medtronic's Harmony TPV System Gains CE Mark for Minimally Invasive Heart Valve Treatment
CompanyMedical Device

Medtronic’s Harmony TPV System Gains CE Mark for Minimally Invasive Heart Valve Treatment

Biocytogen and Acepodia Partner to Develop Dual-Payload Bispecific ADCs for Oncology
CompanyDeals

Biocytogen and Acepodia Partner to Develop Dual-Payload Bispecific ADCs for Oncology

Sanofi's Sarclisa Gains NMPA Approval for Multiple Myeloma Treatment in China
CompanyDrug

Sanofi’s Sarclisa Gains NMPA Approval for Multiple Myeloma Treatment in China

Araris Biotech and Chugai Pharmaceutical Collaborate on Novel ADC Development
CompanyDeals

Araris Biotech and Chugai Pharmaceutical Collaborate on Novel ADC Development

Mirror Biologics and Merck KGaA Collaborate on Phase II Trial for Colorectal Cancer Immunotherapy
CompanyDeals

Mirror Biologics and Merck KGaA Collaborate on Phase II Trial for Colorectal Cancer Immunotherapy

Johnson & Johnson's Posdinemab Receives FDA Fast Track Designation for Alzheimer’s Disease
CompanyDrug

Johnson & Johnson’s Posdinemab Receives FDA Fast Track Designation for Alzheimer’s Disease

Boston Scientific Set to Acquire Bolt Medical for Up to USD 900 Million
CompanyDeals

Boston Scientific Set to Acquire Bolt Medical for Up to USD 900 Million